Hit Enter to search or Esc to close
0
Gefitinib

Gefitinib

CAS NO.:184475-35-2
MF: C22H24ClFN4O3
EINECS NO.:643-034-7
API072
Quantity
Send Inquiry
add to cart

Product Name
Gefitinib
Appearance
White powder
Specification
 99%
Test Method
HPLC
Storage
Keep in a cool, dry, dark location in a tightly sealed container or cylinder.
Shelf Time
24 months
  Boiling point586.8±50.0 °C(Predicted)
  Density1.322±0.06 g/cm3(Predicted)
  Solubility Soluble in DMSO (up to 40mg/ml) or ethanol (up to 4mg/ml)
  pKa7.00±0.10(Predicted)

Gefitinib is a tyrosine kinase inhibitor used

as first-line therapy to treat non-small cell lung carcinoma (NSCLC) that meets certain genetic mutation criteria.

Gefitinib for the continued treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of either platinum-based or docetaxel chemotherapies.